Using Cardicor as first-line therapy in heart failure : CiBis iii.
出版信息
Cardiovasc J Afr. 2009 Jan-Feb;20(1):78.
PMID:19382368
Abstract
摘要
相似文献
1
Using Cardicor as first-line therapy in heart failure : CiBis iii.
Cardiovasc J Afr. 2009 Jan-Feb;20(1):78.
2
[Chronic heart failure and sudden death: the message of CIBIS-III].
Recenti Prog Med. 2007 Dec;98(12):638-45.
3
[Beginning therapy of heart failure with beta blockers. Do these patients survive longer?].
MMW Fortschr Med. 2005 Sep 29;147(39):10.
4
Comparison of treatment initiation with bisoprolol vs. enalapril in chronic heart failure patients: rationale and design of CIBIS-III.
Eur J Heart Fail. 2004 Jun;6(4):493-500. doi: 10.1016/j.ejheart.2003.12.016.
5
[Longevity promoting beta blocker. Soon in 1st place in heart failure?].
MMW Fortschr Med. 2003 Sep 11;145(37):60.
6
Influence of order and type of drug (bisoprolol vs. enalapril) on outcome and adverse events in patients with chronic heart failure: a post hoc analysis of the CIBIS-III trial.
Eur J Heart Fail. 2011 Jul;13(7):765-72. doi: 10.1093/eurjhf/hfr051. Epub 2011 May 6.
7
[Risk reduction of acute heart failure with initial administration of beta-blockers].
Med Monatsschr Pharm. 2007 Apr;30(4):158.
8
Effect on survival and hospitalization of initiating treatment for chronic heart failure with bisoprolol followed by enalapril, as compared with the opposite sequence: results of the randomized Cardiac Insufficiency Bisoprolol Study (CIBIS) III.
Circulation. 2005 Oct 18;112(16):2426-35. doi: 10.1161/CIRCULATIONAHA.105.582320. Epub 2005 Sep 4.
9
Effect on mode of death of heart failure treatment started with bisoprolol followed by Enalapril, compared to the opposite order: results of the randomized CIBIS III trial.
Cardiovasc Ther. 2011 Apr;29(2):89-98. doi: 10.1111/j.1755-5922.2010.00185.x.
10
CIBIS III trial: Bisoprolol treatment for CHF leads to 46% reduction in sudden death after one year.
Cardiovasc J S Afr. 2006 Sep-Oct;17(5):278.
Zotero 插件